{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:14Z","timestamp":1793442674709,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115416","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:18:19Z","timestamp":1790608699000},"page":"115416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Strategies to enhance drug retention after intratumoral and locoregional therapy: A scoping review"],"prefix":"10.1016","volume":"399","author":[{"given":"Berkay","family":"Demirors","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Godbole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola Fuentes","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade C.","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riddhima","family":"Puri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal Abhimutt","family":"Mahesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Berrios","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsheen K.","family":"Manaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Veenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jconrel.2026.115416_bb0005","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1078-0432.CCR-21-1963","article-title":"Phase I dose-escalation trial of MIW815 (ADU-S100), an intratumoral STING agonist, in patients with advanced\/metastatic solid tumors or lymphomas","volume":"28","author":"Meric-Bernstam","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115416_bb0010","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1158\/1078-0432.CCR-24-2824","article-title":"Intratumoral or subcutaneous MK-2118, a noncyclic dinucleotide STING agonist, with or without pembrolizumab, for advanced or metastatic solid tumors or lymphomas","volume":"31","author":"Luke","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115416_bb0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jconrel.2026.115416_bb0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jconrel.2023.11.044","article-title":"CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy","volume":"365","author":"M\u00f6ckel","year":"2024","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115416_bb0025","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1021\/acs.molpharmaceut.7b00475","article-title":"Normalizing tumor vessels to increase the enzyme-induced retention and targeting of gold nanoparticle for breast cancer imaging and treatment","volume":"14","author":"Xiao","year":"2017","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115416_bb0030","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1158\/0008-5472.CAN-22-2838","article-title":"Angiopoietin-2\u2013dependent spatial vascular destabilization promotes T-cell exclusion and limits immunotherapy in melanoma","volume":"83","author":"Park","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115416_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/1061186X.2025.2534184","article-title":"The enhanced surface permeability and retention effect of topically administrated nanoparticles","volume":"34","author":"Chen","year":"2026","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115416_bb0055","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70233-5","article-title":"Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma","volume":"10","author":"Gabriel","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115416_bb0140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jconrel.2020.05.003","article-title":"In situ forming implants exposed to ultrasound enhance therapeutic efficacy in subcutaneous murine tumors","volume":"324","author":"Jeganathan","year":"2020","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115416_bb0095","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/s41590-024-01925-7","article-title":"Local delivery of cell surface-targeted immunocytokines programs systemic antitumor immunity","volume":"25","author":"Santollani","year":"2024","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115416_bb0100","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2326-6066.CIR-23-0636","article-title":"CLN-617 retains IL2 and IL12 in injected tumors to drive robust and systemic immune-mediated antitumor activity","volume":"12","author":"Mehta","year":"2024","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115416_bb0035","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3390\/ijms27020770","article-title":"Modulation of the receptor tyrosine kinase TIE2\/Tek pathway by NRF2 activation in neurovascular endothelial cells","volume":"27","author":"Cazalla","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115416_bb0040","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1158\/0008-5472.CAN-10-3242","article-title":"Antiangiogenesis enhances intratumoral drug retention","volume":"71","author":"Ma","year":"2011","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115416_bb0045","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/1878-0261.12599","article-title":"Rapid stromal remodeling by short-term VEGFR2 inhibition increases chemotherapy delivery in esophagogastric adenocarcinoma","volume":"14","author":"Steins","year":"2020","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.jconrel.2026.115416_bb0060","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1021\/acsbiomaterials.4c00078","article-title":"Liposomal phenylephrine nanoparticles enhance the antitumor activity of intratumoral chemotherapy in a preclinical model of melanoma","volume":"10","author":"Gabriel","year":"2024","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2026.115416_bb0065","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.2147\/IJN.S308057","article-title":"Intratumoral administration of thermosensitive hydrogel co-loaded with norcantharidin nanoparticles and doxorubicin for the treatment of hepatocellular carcinoma","author":"Gao","year":"2021","journal-title":"Int. J. Nanomedicine"},{"issue":"28","key":"10.1016\/j.jconrel.2026.115416_bb0070","doi-asserted-by":"crossref","first-page":"18604","DOI":"10.1021\/acsnano.4c04766","article-title":"Multifunctional nanoparticle-loaded injectable alginate hydrogels with deep tumor penetration for enhanced chemo-immunotherapy of cancer","volume":"18","author":"Yang","year":"2024","journal-title":"ACS Nano"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115416_bb0075","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/pharmaceutics13111953","article-title":"Advances in injectable in situ-forming hydrogels for intratumoral treatment","volume":"13","author":"Shin","year":"2021","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115416_bb0080","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.3390\/pharmaceutics15041071","article-title":"In situ-forming gels loaded with stimuli-responsive gated mesoporous silica nanoparticles for local sustained drug delivery","volume":"15","author":"De La Torre","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115416_bb0085","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1038\/s41598-024-57664-0","article-title":"Injectable hydrogel with doxorubicin-loaded ZIF-8 nanoparticles for tumor postoperative treatments and wound repair","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2026.115416_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2024.1325204","article-title":"Stimuli-responsive hydrogel based on natural polymers for breast cancer","volume":"12","author":"Asadi","year":"2024","journal-title":"Front. Chem."},{"key":"10.1016\/j.jconrel.2026.115416_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216859","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: challenges and opportunities","volume":"591","author":"Qin","year":"2024","journal-title":"Cancer Lett."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115416_bb0110","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/biom14111458","article-title":"Tumor-colonizing E. Coli expressing both collagenase and hyaluronidase enhances therapeutic efficacy of gemcitabine in pancreatic cancer models","volume":"14","author":"Avsharian","year":"2024","journal-title":"Biomolecules"},{"issue":"23","key":"10.1016\/j.jconrel.2026.115416_bb0115","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2421061122","article-title":"Sequential drug release system: targeting the tumor ECM for enhanced chemotherapy efficacy","volume":"122","author":"Cao","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115416_bb0120","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7150\/thno.47446","article-title":"Collagenase IV and clusterin-modified polycaprolactone-polyethylene glycol nanoparticles for penetrating dense tumor tissues","volume":"11","author":"Huang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115416_bb0125","first-page":"100489","article-title":"A pH-responsive dual-drug nanoplatform for stromal remodeling and enhanced chemotherapy via MMP3\/TGF-\u03b2 inhibition","volume":"11","author":"Tan","year":"2026","journal-title":"Int. J. Pharm. X"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115416_bb0130","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ccell.2021.02.007","article-title":"Type I collagen deletion in \u03b1SMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer","volume":"39","author":"Chen","year":"2021","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115416_bb0135","doi-asserted-by":"crossref","first-page":"15798","DOI":"10.1038\/s41598-023-42786-8","article-title":"Drug delivery by sonosensitive liposome and microbubble with acoustic-lens attached ultrasound: an in vivo feasibility study in a murine melanoma model","volume":"13","author":"Park","year":"2023","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115416_bb0145","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1248\/bpb.b17-00730","article-title":"Involvement of tumor lymphatic system in translocation of intratumorally injected liposomes","volume":"41","author":"Shimizu","year":"2018","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115416_bb0150","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat. Commun."},{"issue":"43","key":"10.1016\/j.jconrel.2026.115416_bb0155","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.3c12337","article-title":"Robust and sustained STING pathway activation via hydrogel-based in situ vaccination for cancer immunotherapy","volume":"18","author":"Cheng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.115416_bb0160","article-title":"Intratumoral injection of anlotinib hydrogel combined with radiotherapy reduces hypoxia in Lewis lung carcinoma xenografts: assessment by micro fluorine-18-fluoromisonidazole positron emission tomography\/computed tomography hypoxia imaging","volume":"11","author":"Gao","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115416_bb0165","doi-asserted-by":"crossref","first-page":"7595","DOI":"10.1021\/acsabm.1c00864","article-title":"Injectable and thermosensitive liposomal hydrogels for NIR-II light-triggered photothermal-chemo therapy of pancreatic cancer","volume":"4","author":"Kong","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2026.115416_bb0170","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.canlet.2018.11.011","article-title":"Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity","volume":"442","author":"Yu","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.115416_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1291530","article-title":"Targeting vascular normalization: a promising strategy to improve immune\u2013vascular crosstalk in cancer immunotherapy","volume":"14","author":"Qian","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.115416_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1141712","article-title":"Adrenergic receptor signaling regulates the CD40-receptor mediated anti-tumor immunity","volume":"14","author":"Singh","year":"2023","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.jconrel.2026.115416_bb0185","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1158\/1078-0432.CCR-24-3630","article-title":"Phase I and II clinical studies of the STING agonist ulevostinag with and without pembrolizumab in participants with advanced or metastatic solid tumors or lymphomas","volume":"31","author":"Harrington","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115416_bb0190","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyae200","article-title":"Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancer","volume":"30","author":"Runcie","year":"2025","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115416_bb0195","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1038\/s41467-024-54877-9","article-title":"Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity","volume":"15","author":"Hamouda","year":"2024","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115416_bb0200","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3390\/cancers18081284","article-title":"Balancing tumor response and rejection risk after pre-transplant immunotherapy: a scoping review","volume":"18","author":"Demirors","year":"2026","journal-title":"Cancers"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:43:28Z","timestamp":1793439808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S0168365926008205"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115416","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies to enhance drug retention after intratumoral and locoregional therapy: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115416"}}